Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/9476

Target Organs and Levels of Evidence for TR-370

Toxicology and Carcinogenesis Studies of Benzofuran (CASRN 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Benzofuran
271-89-6
03/13/1989 Gavage
FR&MM: 0,60,120, MR: 0,30,60, FM: 0,120,240 MG/KG/50 PER GROUP
Springborn Inst. for Bioresearch, Inc.

Levels of Evidence

Male Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • KIDNEY: INCREASED SEVERITY OF NEPHROPATHY
Female Rats: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Kidney Tubular Cell: ADENOCARCINOMA 0/50 1/50 4/50
Non-Neoplastic Lesions
  • KIDNEY: NEPHROPATHY 29/50 48/50 39/50
  • PANCREAS: METAPLASIA 0/50 1/50 11/49
Male Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 4/49 24/39 34/48; HEPATOBLASTOMA 0/49 3/39 18/48; ADENOMA, HEPATOBLASTOMA, OR CARCINOMA 9/49 8/39 9/48 COMBINED 12/49 31/39 40/48
  • Forestomach: SQUAMOUS CELL PAPILLOMA 2/49 7/39 10/48 OR SQUAMOUS CELL CARCINOMA 0/49 4/39 3/48 COMBINED 2/49 11/39 13/48
  • Lung: ALVEOLAR/BRONCHIOLAR ADENOMA 4/49 7/39 15/48 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 7/49 3/39 5/48 COMBINED 10/49 9/39 19/48
Non-Neoplastic Lesions
  • LIVER: SYNCYTIAL ALTERATION 4/49 18/39 36/48
  • LUNG: BRONCHIAL EPITHELIAL HYPERPLASIA 3/49 11/39 14/48
  • FORESTOMACH: EPITHELIAL HYPERPLASIA 16/49 13/39 24/48
Female Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 1/50 22/48 21/47; HEPATOBLASTOMA 0/50 1/48 2/47; ADENOMA, HEPATOBLASTOMA, OR CARCINOMA 3/50 3/48 1/47 COMBINED 4/50 25/48 22/47
  • Lung: ALVEOLAR/BRONCHIOLAR ADENOMA 1/50 5/48 13/47 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 4/48 3/47 COMBINED 2/50 9/48 14/47
  • Forestomach: SQUAMOUS CELL PAPILLOMA 2/50 8/50 5/50 OR SQUAMOUS CELL CARCINOMA 0/50 1/50 1/50 COMBINED 2/50 9/50 5/50
Non-Neoplastic Lesions
  • LIVER: SYNCYTIAL ALTERATION 1/50 0/48 2/47
  • LUNG: BRONCHIAL EPITHELIAL HYPERPLASIA 1/50 22/48 34/47
  • FORESTOMACH: EPITHELIAL HYPERPLASIA 7/50 19/48 13/47